Epinoma is an early-stage biotechnology company developing a novel method to quantify epigenetic signals for early-stage cancer detection and minimal residual disease (MRD) monitoring. Early backers of the company include renowned Harvard geneticist Dr. George Church, and the company has also built a strong research collaboration with researchers at TU Dortmund in Germany.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 10/22/21 | undisclosed |
SeedtoB Capital | undisclosed |
